Corneal Adverse Events Temporally Associated with Anti-TNF-α Therapy: Severe Fibrovascular Pannus and a Non-Pannus Epitheliopathy in Two Cases
Open Access
- 1 October 2025
- journal article
- case report
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 1285-1289
Abstract
Purpose: To describe two corneal adverse events temporally associated with anti–tumor necrosis factor-α (TNF-α) therapy—one with severe fibrovascular pannus and another with epithelial keratopathy without pannus. Methods: Two patients on anti-TNF-α agents underwent comprehensive ocular examinations. Management included modification or discontinuation of biologics as clinically indicated and intensified topical therapy. Results: Case 1 (pustular psoriasis on adalimumab) developed bilateral fibrovascular pannus with stromal changes. Ocular findings did not improve immediately after adalimumab discontinuation but gradually improved following macrolide, topical corticosteroid, and immunomodulatory therapy. Case 2 (Crohn’s disease on adalimumab then golimumab) presented with superior corneal haze and diffuse superficial punctate keratopathy without pannus and resolved with topical therapy alone. Conclusion: These cases raise the possibility that corneal adverse events—including severe pannus—may occur during anti-TNF-α therapy. Given the heterogeneity and potential confounders, causality cannot be established. Ophthalmic vigilance and further studies are warranted.Keywords
This publication has 12 references indexed in Scilit:
- Meibomian Glands and Ocular Surface InflammationThe Ocular Surface, 2015
- Anti-TNF therapy: past, present and futureInternational Immunology, 2014
- Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory DisordersOphthalmology, 2014
- Sight-threatening Keratopathy Complicating Anti-TNF Therapy in Crohnʼs DiseaseInflammatory Bowel Diseases, 2014
- Tuberous Sclerosis Complex: Genotype/Phenotype Correlation of Retinal FindingsOphthalmology, 2012
- Scleritis: A Paradoxical Effect of Etanercept? Etanercept-associated Inflammatory Eye DiseaseThe Journal of Rheumatology, 2011
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)Annals of the Rheumatic Diseases, 2010
- The probable associations for corticocapsular adhesions in patients undergoing cataract surgery: A clinic-based observational studyIndian Journal Of Ophthalmology, 2008
- Do tumor necrosis factor inhibitors cause uveitis? A registry‐based studyArthritis & Rheumatism, 2007
- Corneal neovascularizationCurrent Opinion in Ophthalmology, 2001